Non-invasive radiofrequency ablation of malignancies mediated by quantum dots, gold nanoparticles and carbon nanotubes

Therapeutic Delivery

Volumn 2, Issue 10, 2011, Pages 1325-1330

  Glazer, Evan S ^a   Curley, Steven A ^b  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTINEOPLASTIC AGENT; CARBON NANOTUBE; CETUXIMAB; GOLD NANOPARTICLE; NANOPARTICLE; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; PROTEIN; QUANTUM DOT; SINGLE WALLED NANOTUBE; TRASTUZUMAB;

ACUTE TOXICITY; CANCER CELL; CANCER CONTROL; CHRONIC TOXICITY; CYTOTOXICITY; DRUG EFFICACY; DRUG MONITORING; DRUG SAFETY; IMAGING; IN VIVO STUDY; IONIZING RADIATION; MALIGNANT NEOPLASTIC DISEASE; MULTIMODALITY CANCER THERAPY; NON INVASIVE PROCEDURE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RADIATION EXPOSURE; RADIATION FIELD; RADIOFREQUENCY ABLATION; RADIOFREQUENCY RADIATION; REVIEW; TUMOR NECROSIS;

EID: 80054113107     PISSN: 20415990     EISSN: 20416008     Source Type: Journal    
DOI: 10.4155/tde.11.102     Document Type: Review

References (30)

1. Curley SA. Radiofrequency ablation leads to excellent local tumor control and durable longterm survival in specific subsets of early stage HCC patients confirming to the Milan criteria. Ann. Surg. 252(6), 913-914 (2010)
2. Yu J, Liang P, Yu X, Liu F, Chen L, Wang Y. A comparison of microwave ablation and bipolar radiofrequency ablation both with an internally cooled probe: Results in ex vivo and in vivo porcine livers. Eur. J.Radiol. 79(1), 124-130 (2011)
3. Curley SA. Radiofrequency ablation versus resection for resectable colorectal liver metastases: time for a randomized trial? Ann. Surg. Oncol. 15(1), 11-13 (2008)
4. Fernando HC, De Hoyos A, Landreneau RJ et al. Radiofrequency ablation for the treatment of non-small cell lung cancer in marginal surgical candidates. J. Thorac. Cardiovasc. Surg. 129(3), 639-644 (2005) (Pubitemid 40311325)
5. Abdellaoui A, Watkinson AF. Radiofrequency ablation of renal tumors. Future Oncol. 4(1), 103-111 (2008) (Pubitemid 351372611)
6. Roschmann P. Radiofrequency penetration and absorption in the human body: limitations to high-field whole-body nuclear magnetic resonance imaging. Med. Phys. 14(6), 922-931 (1987) (Pubitemid 18025944)
7. Cheung AY, Neyzari A. Deep local hyperthermia for cancer therapy: external electromagnetic and ultrasound techniques. Cancer Res. 44(Suppl. 10), 4736s-4744s (1984) (Pubitemid 14000090)
8. Letfullin RR, Iversen CB, George TF. Modeling nanophotothermal therapy: kinetics of thermal ablation of healthy and cancerous cell organelles and gold nanoparticles. Nanomedicine 7(2), 137-145 (2011)
9. Cherukuri P, Glazer ES, Curley SA. Targeted hyperthermia using metal nanoparticles. Adv. Drug Deliv. Rev. 62(3), 339-345 (2010)
10. Glazer ES, Zhu C, Massey KL et al. Noninvasive radiofrequency field destruction of pancreatic adenocarcinoma xenografts treated with targeted gold nanoparticles. Clin. Cancer Res. 16(23), 5712-5721 (2010)
11. Choi WI, Kim JY, Kang C, Byeon CC, Kim YH, Tae G. Tumor regression in vivo by photothermal therapy based on gold-nanorod-loaded, functional nanocarriers. ACS Nano 5(3), 1995-2003 (2011)
12. Cardinal J, Klune JR, Chory E et al. Noninvasive radiofrequency ablation of cancer targeted by gold nanoparticles. Surgery 144(2), 125-132 (2008) (Pubitemid 352010312)
13. Glazer ES, Zhu C, Hamir AN, Borne A, Thompson CS, Curley SA. Biodistribution and acute toxicity of naked gold nanoparticles in a rabbit hepatic tumor model. Nanotoxicology DOI: 10.3109/ 17435390.2010.516026 (2010)
14. Donaldson K, Murphy F, Schinwald A, Duffin R, Poland CA. Identifying the pulmonary hazard of high aspect ratio nanoparticles to enable their safety-by-design. Nanomedicine 6(1), 143-156 (2011)
15. Moran CH, Wainerdi SM, Cherukuri TK et al. Size-dependent joule heating of gold nanoparticles using capacitively coupled radiofrequency fields. Nano Res. 2(5), 400-405 (2009)
16. Curley SA, Cherukuri P, Briggs K et al. Noninvasive radiofrequency field-induced hyperthermic cytotoxicity in human cancer cells using cetuximab-targeted gold nanoparticles. J. Exp. Ther. Oncol. 7(4), 313-326 (2008)
17. Glazer ES, Curley SA. Radiofrequency field-induced thermal cytotoxicity in cancer cells treated with fluorescent nanoparticles. Cancer 116(13), 3285-3293 (2010)
18. Gannon CJ, Cherukuri P, Yakobson BI et al. Carbon nanotube-enhanced thermal destruction of cancer cells in a noninvasive radiofrequency field. Cancer 110(12), 2654-2665 (2007) (Pubitemid 350250334)
19. Li D, Jung YS, Tan S, Kim HK, Chory E, Geller DA. Negligible absorption of radiofrequency radiation by colloidal gold nanoparticles. J. Colloid. Interface Sci. 358(1), 47-53 (2011)
20. Nergiz SZ, Singamaneni S. Reversible tuning of plasmon coupling in gold nanoparticle chains using ultrathin responsive polymer film. ACS Appl. Mater. Interfaces 3(4), 945-951 (2011)
21. Wardle EN. Kupffer cells and their function. Liver 7(2), 63-75 (1987) (Pubitemid 17112157)
22. Glazer ES, Zhu C, Massey KL et al. Noninvasive radiofrequency field destruction of pancreatic adenocarcinoma xenografts treated with targeted gold nanoparticles. Clin. Cancer Res. 16(23), 5712-5721 (2010)
23. Khan JA, Kudgus RA, Szabolcs A et al. Designing nanoconjugates to effectively target pancreatic cancer cells in vitro and in vivo. PLoS One 6(6), e20347 (2011)
24. Almeida JP, Chen AL, Foster A, Drezek R. In vivo biodistribution of nanoparticles. Nanomedicine 6(5), 815-835 (2011)
25. Ali MM, Yoo B, Pagel MD. Tracking the relative in vivo pharmacokinetics of nanoparticles with PARACEST MRI. Mol. Pharm. 6(5), 1409-1416 (2009)
26. Warsi MF, Chechik V. Strategies for increasing relaxivity of gold nanoparticle based MRI contrast agents. Phys. Chem. Chem. Phys. 13(20), 9812-9817 (2011)
27. Portney NG, Ozkan M. Nano-oncology: drug delivery, imaging, and sensing. Anal. Bioanal. Chem. 384(3), 620-630 (2006) (Pubitemid 43237915)
28. Tiwari DK, Jin T, Behari J. Bio-distribution and toxicity assessment of intravenously injected anti-HER2 antibody conjugated CdSe/ZnS quantum dots in Wistar rats. Int. J. Nanomedicine 6, 463-475 (2011)
29. Mo SM, Oh IJ. Release of adriamycin from poly(lactide-co-glycolide)- polyethylene glycol nanoparticles. J. Nanosci. Nanotechnol. 11(2), 1795-1798 (2011)
30. Butterworth KT, Coulter JA, Jain S et al. Evaluation of cytotoxicity and radiation enhancement using 1.9 nm gold particles: potential application for cancer therapy. Nanotechnology 21(29), 295101 (2010).